Buy GLP-1 + GIP (Tirzepatide)
Lose Weight with Leanefy - Metabolic Reset Clinic
HypoSpray | Needle-Free Therapeutic Delivery
Needle-Free Therapeutic Delivery

Stop Injecting.
Start Spraying.

HypoSpray® is positioned as a transdermal delivery platform for select therapies, built around simple daily use, patient comfort, and telehealth-friendly care.

Needle-Free
Daily Dosing
Telehealth Friendly
Multi-Therapy Platform
HypoSpray platform visual
Core Positioning
A therapeutic delivery platform designed to support modern telehealth medicine.
Needle-Free

Built to remove injection friction and anxiety.

Daily Routine

Five-day pattern with weekend rest days.

Patient Comfort

Simple use, less stress, easier to stay consistent.

Telehealth Ready

Positioned for remote care workflows and easy onboarding.

Why This Exists

Traditional injections create friction. HypoSpray is designed to reduce it.

Most traditional therapies come with weekly injections that can feel uncomfortable, hard to maintain, and difficult to manage at home. HypoSpray changes that.

Why current delivery falls short
Needle-free administration

HypoSpray replaces weekly injections with a simple daily spray — no needles, no syringes, no anxiety.

Physiologic daily dosing

The tirzepatide protocol uses a five-day weekly routine instead of a single weekly shot.

Patient experience first

Our telehealth care model puts patient comfort, adherence, and long-term retention at the center of every treatment plan.

Platform architecture

HypoSpray is designed as a scalable delivery system — not just a single therapy, but a foundation for multiple treatment programs.

Use Cases

Who is HypoSpray for?

HypoSpray is designed for a wide range of patients — from those managing weight to those seeking a more comfortable daily treatment experience.

Metabolic Health

Weight Management Programs

Fits tirzepatide-based and GLP-1 / GLP-1-GIP style programs where patients want a simpler daily routine.

Glycemic Support

Type 2 Diabetes Support

The infographic reports improved HbA1c, reduced insulin use, and stronger CGM metrics over the observed period.

Needle-Free

Patients Who Hate Injections

Built for people who avoid needles, dislike self-injection, or want a more comfortable treatment journey.

Telehealth

Remote Care Workflows

Designed for remote care workflows — simple onboarding, no injection training required, and a patient-friendly daily routine.

Hormone Programs

TRT / HRT Programs

HypoSpray is built to scale into hormone replacement programs including TRT and HRT as future therapeutic categories.

Future Pipeline

Peptides & Longevity

HypoSpray's delivery architecture is designed to expand into peptides, longevity molecules, and next-generation biologics.

Benefits

Why patients and providers may prefer HypoSpray

Patients and providers are choosing HypoSpray for its simplicity, comfort, and telehealth-friendly design.

Needle-Free Delivery

No routine injections, no injection anxiety, and no self-injection learning curve.

Clear Weekly Routine

A simple five-day weekly schedule that is easy to understand, easy to follow, and easy to stay consistent with.

Better Patient Comfort

A less intimidating route of administration can make treatment feel easier to start and maintain.

Telehealth Friendly

Fits remote care workflows because it reduces injection instruction and onboarding complexity.

Operational Simplicity

Simple application, room-temperature storage, and no special training required — making it ideal for home use.

Expandable Platform

HypoSpray is built as a delivery architecture that can support multiple therapeutic programs beyond weight management.

Clinical Highlight

Reported outcomes from the single-subject evaluation

Results from a 29-month individual evaluation conducted while using HypoSpray as the primary delivery method.

8.2% → 6.8%
HbA1c improvement over the observed period.
600 → 220 IU/day
Daily insulin requirement reduced over the observation period.
268 → 225 lbs
Body weight reduction over the observation period.
TIR 82%
Best reported Time In Range with GMI 6.6%.

The infographic describes a 29-month single-subject longitudinal evaluation in which subcutaneous injection was used at first, followed by HypoSpray HDS-A as the primary delivery modality from week 3 onward.

Clinical evaluation infographic
Note: Results are based on a single-subject, 29-month longitudinal evaluation. Individual results may vary.
How It Works

Simple daily application. Clear weekly rhythm.

A straightforward five-day weekly schedule with weekend rest days — designed to fit easily into your daily life.

Administration instructions
Prepare

Choose a clean site such as forearm, chest, shoulder, or thigh. Wash and pat dry before use.

Apply

Hold the bottle close to the skin and spray directly onto the site using the prescribed number of sprays.

Wait

Let the spray dry completely before covering or dressing the area.

Schedule

Use the therapy five days per week at the same time each day, with Saturday and Sunday as rest days.

Rotate

Alternate application sites each day to minimize irritation and avoid the same spot for at least three days.

Comparison

Why the platform feels different from traditional injections

See how HypoSpray compares to traditional weekly injections across comfort, convenience, and daily experience.

Traditional Injections HypoSpray
Needles required Needle-free delivery
Self-injection training Simple spray application
Weekly or intermittent dosing Daily five-day routine
More friction for patients More comfortable experience
Injection instruction burden Telehealth-friendly workflow
Single-therapy framing Platform architecture for multiple therapies
Platform expansion
Platform Expansion

One delivery platform. Multiple therapeutic programs.

HypoSpray is designed as a delivery platform that can scale across multiple therapeutic programs — from metabolic health to hormones, peptides, longevity molecules, and future biologics.

TRT HRT Peptides Metabolic Therapies Longevity
HypoSpray is built around delivery — giving patients access to multiple therapeutic programs through one simple, needle-free platform.
FAQ

Common questions about HypoSpray

Everything you need to know about HypoSpray — how it works, who it's for, and what to expect from your first order.

HypoSpray is presented as a needle-free transdermal delivery platform designed to support select therapies through a simple daily spray routine.

The uploaded decks position it for patients seeking needle-free therapy, telehealth-compatible care, metabolic programs, and broader hormone or peptide platform use.

Yes, but only in a single-subject 29-month longitudinal infographic. It should be described carefully as reported outcomes, not as broad clinical proof for all patients.

Results may vary based on individual health profile, dosage, and treatment duration. The best way to understand what to expect is to consult with one of our licensed providers during your initial evaluation.
Ready to Get Started?

A simpler, needle-free experience for modern therapy programs.

Experience the comfort of needle-free therapy — designed for your daily routine and supported by our licensed telehealth providers, 7 days a week.

Disclaimer: Results are based on a single-subject, 29-month longitudinal evaluation. Individual results may vary. HypoSpray is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new therapy.
This website uses cookies to ensure you get the best experience on our website.Please view our Cookie Policy for more information.